Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sohrab Shah

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2023
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric CancerSteven B Maron, Walid Chatila, Henry Walch, et al.
Nature Communications|June 7, 2016
Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapesBernard Pereira, Suet-Feung Chin, Oscar M Rueda, et al.
Nature Communications|May 11, 2016
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapesBernard Pereira, Suet-Feung Chin, Oscar M Rueda, et al.
Blood|May 24, 2013
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencingRyan D Morin, Karen Mungall, Erin Pleasance, et al.
NPJ Precision Oncology|March 14, 2024
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
NPJ Precision Oncology|May 6, 2024
Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
Nature Communications|October 3, 2018
Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphomaSarah E Arthur, Aixiang Jiang, Bruno M Grande, et al.
Nature Genetics|January 19, 2010
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center originRyan D Morin, Nathalie A Johnson, Tesa M Severson, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancerAnton Safonov, Antonio Marra, Chaitanya Bandlamudi, et al.
Nature|March 4, 2026
Homologous recombination deficiency and hemizygosity drive resistance in breast cancerAnton Safonov, Minna Lee, David N Brown, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2023
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric CancerSteven B Maron, Walid Chatila, Henry Walch, et al.
Nature Communications|June 7, 2016
Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapesBernard Pereira, Suet-Feung Chin, Oscar M Rueda, et al.
Nature Communications|May 11, 2016
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapesBernard Pereira, Suet-Feung Chin, Oscar M Rueda, et al.
Blood|May 24, 2013
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencingRyan D Morin, Karen Mungall, Erin Pleasance, et al.
NPJ Precision Oncology|March 14, 2024
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
NPJ Precision Oncology|May 6, 2024
Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
Nature Communications|October 3, 2018
Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphomaSarah E Arthur, Aixiang Jiang, Bruno M Grande, et al.
Nature Genetics|January 19, 2010
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center originRyan D Morin, Nathalie A Johnson, Tesa M Severson, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancerAnton Safonov, Antonio Marra, Chaitanya Bandlamudi, et al.
Nature|March 4, 2026
Homologous recombination deficiency and hemizygosity drive resistance in breast cancerAnton Safonov, Minna Lee, David N Brown, et al.
Pageof 4